Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 19707443)

  • 1. Rituximab in the treatment of non-Hodgkin's lymphoma.
    Hauptrock B; Hess G
    Biologics; 2008 Dec; 2(4):619-33. PubMed ID: 19707443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The therapeutic use of rituximab in non-Hodgkin's lymphoma.
    Marcus R; Hagenbeek A
    Eur J Haematol Suppl; 2007 Jan; (67):5-14. PubMed ID: 17206982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma.
    Fanale MA; Younes A
    Drugs; 2007; 67(3):333-50. PubMed ID: 17335294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost-effectiveness of rituximab in non-Hodgkin's lymphoma.
    Knight C; Maciver F
    Expert Rev Pharmacoecon Outcomes Res; 2007 Aug; 7(4):319-26. PubMed ID: 20528413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffuse aggressive lymphoma.
    Fisher RI; Miller TP; O'Connor OA
    Hematology Am Soc Hematol Educ Program; 2004; ():221-36. PubMed ID: 15561685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
    Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
    Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New developments in immunotherapy for non-Hodgkin's lymphoma.
    Leonard JP; Furman RR; Ruan J; Coleman M
    Curr Oncol Rep; 2005 Sep; 7(5):364-71. PubMed ID: 16091197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy combinations with monoclonal antibodies in non-Hodgkin's lymphoma.
    Kahl B
    Semin Hematol; 2008 Apr; 45(2):90-4. PubMed ID: 18381103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunochemotherapy: the new standard in aggressive non-Hodgkin's lymphoma in the elderly.
    Coiffier B
    Semin Oncol; 2003 Feb; 30(1 Suppl 2):21-7. PubMed ID: 12652461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended Rituximab (anti-CD20 monoclonal antibody) therapy for relapsed or refractory low-grade or follicular non-Hodgkin's lymphoma.
    Piro LD; White CA; Grillo-López AJ; Janakiraman N; Saven A; Beck TM; Varns C; Shuey S; Czuczman M; Lynch JW; Kolitz JE; Jain V
    Ann Oncol; 1999 Jun; 10(6):655-61. PubMed ID: 10442187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the role of maintenance rituximab in follicular NHL?
    Maloney DG
    Oncology (Williston Park); 2008 Jan; 22(1):20-6; discussion 26, 29, 33-4. PubMed ID: 18251281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A decade of rituximab: improving survival outcomes in non-Hodgkin's lymphoma.
    Molina A
    Annu Rev Med; 2008; 59():237-50. PubMed ID: 18186705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rituximab].
    Okamoto R; Maeda Y; Sasaki T
    Gan To Kagaku Ryoho; 2003 Aug; 30(8):1085-93. PubMed ID: 12938262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab.
    Boye J; Elter T; Engert A
    Ann Oncol; 2003 Apr; 14(4):520-35. PubMed ID: 12649096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced efficacy of gemcitabine in combination with anti-CD20 monoclonal antibody against CD20+ non-Hodgkin's lymphoma cell lines in vitro and in scid mice.
    Smith MR; Joshi I; Jin F; Obasaju C
    BMC Cancer; 2005 Aug; 5():103. PubMed ID: 16109167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials of a mouse-human chimeric anti-CD20 monoclonal antibody (rituximab) for B cell non-Hodgkin's lymphoma in Japan.
    Tobinai K
    Cancer Chemother Pharmacol; 2001 Aug; 48 Suppl 1():S85-90. PubMed ID: 11587374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New treatment approaches to indolent non-Hodgkin's lymphoma.
    Seymour JF
    Semin Oncol; 2004 Feb; 31(1 Suppl 2):27-32. PubMed ID: 15042532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Treatment Approaches To Indolent Non-Hodgkin's Lymphoma.
    Seymour JF
    Semin Oncol; 2004 Feb; 31 Suppl 2():27-32. PubMed ID: 28140107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab in combination with CHOP improves survival in elderly patients with aggressive non-Hodgkin's lymphoma.
    Coiffier B
    Semin Oncol; 2002 Apr; 29(2 Suppl 6):18-22. PubMed ID: 12040530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.